Similarly, an extensive U.S. cohort study identified TACI as the most frequent genetic defect and found that autoimmune manifestations—particularly AIHA and ITP—were significantly more common in TACI-mutated patients [24]. This evidence concerns the gene TNFRSF13B and autoimmune hemolytic anemia.